ALLISON GOLDEN, CRNP
Nurse Practitioner · HERSHEY, PA
Individual Active NPI 1295123354
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 351 | 665 | $137,227 | $29,697 | $19,943 |
| 2023 | 327 | 608 | $122,933 | $26,941 | $18,307 |
| 2022 | 303 | 584 | $98,054 | $25,159 | $15,581 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 269 | $53 | $36 |
| 17000 | Destruction of precancer skin growth, 1 growth | 108 | $44 | $28 |
| 17003 | Destruction of precancer skin growth, 2-14 growths | 62 | $2 | $1 |
| 11102 | Biopsy of related skin growth, first growth | 57 | $26 | $19 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 42 | $53 | $37 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 40 | $79 | $55 |
| 11103 | Biopsy of related skin growth, each additional growth | 22 | $18 | $14 |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 14 | $68 | $43 |
| 17000 | Destruction of precancer skin growth, 1 growth | 13 | $43 | $26 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Nurse Practitioner | 363L00000X | ✓ | SP014407 | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Nurse Practitioner providers in Pennsylvania
- NPI 1063134997
- NPI 1932068269
- NPI 1881132983
- NPI 1225766546
- NPI 1447868559
- NPI 1518485200
- NPI 1720917479
- NPI 1770133472
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.